CommercialOctober 1, 2019
Important update to Anthem’s commercial drug lists
Effective with dates of service on and after October 1, 2019, and in accordance with Anthem’s Pharmacy and Therapeutic (P&T) process, Anthem will update its commercial drug lists. Updates may include changes to drug tiers or the removal of a drug.
To help ensure a smooth transition and minimize member costs, providers should review these changes and consider prescribing a preferred drug to patients currently using a non-preferred drug, if appropriate.
Please note, this update does not apply to the Select Drug List or drugs lists utilized by the Federal Employee Program (FEP).
To view a summary of changes, open the PDF attached to this article titled “8.1.19 and 10.1.19 Summary_of_formulary_changes”.
ATTACHMENTS: 8.1.19 and 10.1.19_Summary_of_Formulary_Changes.pdf (pdf - 0.1mb)
PUBLICATIONS: October 2019 Provider News
To view this article online:
Or scan this QR code with your phone